Platelet-adenovirus vs. inert particles interaction: Effect on aggregation and the role of platelet membrane receptors

Platelets

Volumn 24, Issue 5, 2013, Pages 383-391

  Gupalo, Elena ^a   Kuk, Cynthia ^b   Qadura, Mohammad ^c   Buriachkovskaia, Liudmila ^a   Othman, Maha ^d,e  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

^e St Lawrence College   (Canada)

Author keywords

Adenovirus; CAR; Covercytes; Microspheres; Platelet integrins; Thrombocytopenia

Indexed keywords

KISTRIN; MICROSPHERE; PADGEM PROTEIN;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; HUMAN; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOPODIUM; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; THROMBOCYTE SHAPE; VIRUS PARTICLE;

ADENOSINE DIPHOSPHATE; ADENOVIRIDAE; BLOOD PLATELETS; ENDOCYTOSIS; HUMANS; INTEGRIN ALPHAVBETA3; MEMBRANE GLYCOPROTEINS; MICROSPHERES; NANOPARTICLES; P-SELECTIN; PEPTIDES; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; VIRUS INTERNALIZATION;

ADENOVIRIDAE;

EID: 84879739868     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2012.703792     Document Type: Article

References (41)

1. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011;105 Suppl. 1:S13-S33
2. White JG. Platelets are covercytes, not phagocytes: Uptake of bacteria involves channels of the open canalicular system. Platelets 2005;16:121-131
3. Youssefian T, Drouin A, Masse JM, Guichard J, Cramer EM. Host defense role of platelets: Engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 2002;99:4021-4029
4. Clawson CC. Platelet interaction with bacteria: 3. Ultrastructure. Am J Pathol 1973;70:449-471
5. Clawson CC, Rao GH, White JG. Platelet interaction with bacteria: IV. Stimulation of the release reaction. Am J Pathol 1975;81:411-420
6. Clawson CC, White JG. Platelet interaction with bacteria: II. Fate of the bacteria. Am J Pathol 1971;65:381-397
7. Ramtoola Z, Lyons P, Keohane K, Kerrigan SW, Kirby BP, Kelly JG. Investigation of the interaction of biodegradable microand nanoparticulate drug delivery systems with platelets. J Pharm Pharmacol 2011;63:26-32
8. Nunez D, Charriaut-Marlangue C, Barel M, Benveniste J, Frade R. Activation of human platelets through gp140, the C3d/ EBV receptor (CR2). Eur J Immunol 1987;17:515-520
9. Zahn A, Jennings N, Ouwehand WH, Allain JP. Hepatitis C virus interacts with human platelet glycoprotein VI. J Gen Virol 2006;87:2243-2251
10. Flaujac C, Boukour S, Cramer-Borde E. Platelets and viruses: An ambivalent relationship. Cell Mol Life Sci 2010;67:545-556
11. Chaipan C, Soilleux EJ, Simpson P, Hofmann H, Gramberg T, Marzi A, Geier M, Stewart EA, Eisemann J, Steinkasserer A, et al. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J Virol 2006;80:8951-8960
12. Coulson BS, Londrigan SL, Lee DJ. Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells. Proc Natl Acad Sci USA 1997;94: 5389-5394
13. Mackow ER, Gavrilovskaya IN. Cellular receptors and hantavirus pathogenesis. Curr Top Microbiol Immunol 2001;256:91-115
14. Maginnis MS, Forrest JC, Kopecky-Bromberg SA, Dickeson SK, Santoro SA, Zutter MM, Nemerow GR, Bergelson JM, Dermody TS. Beta1 integrin mediates internalization of mammalian reovirus. J Virol 2006;80:2760-2770
15. Othman M, Labelle A, Mazzetti I, Elbatarny HS, Lillicrap D. Adenovirus-induced thrombocytopenia: The role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood 2007;109:2832-2839
16. Wolins N, Lozier J, Eggerman TL, Jones E, Aguilar-Cordova E, Vostal JG. Intravenous administration of replication-incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance. Br J Haematol 2003;123:903-905
17. Varnavski AN, Calcedo R, Bove M, Gao G, Wilson JM. Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and preimmunized mice. Gene Ther 2005;12:427-436
18. Cichon G, Schmidt HH, Benhidjeb T, Loser P, Ziemer S, Haas R, Grewe N, Schnieders F, Heeren J, Manns MP, et al. Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J Gene Med 1999;1:360-371
19. Stone D, Liu Y, Shayakhmetov D, Li ZY, Ni S, Lieber A. Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver. J Virol 2007;81:4866-4871
20. Shimony N, Elkin G, Kolodkin-Gal D, Krasny L, Urieli-Shoval S, Haviv YS. Analysis of adenoviral attachment to human platelets. Virol J 2009;6:25
21. Gupalo E, Buriachkovskaia L, Othman M. Human platelets express CAR with localization at the sites of intercellular interaction. Virol J 2011;8:456
22. Zhang Y, Bergelson JM. Adenovirus receptors. J Virol 2005;79:12125-12131
23. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 2006;4:445-457
24. Furie B, Furie BC, Flaumenhaft R. A journey with platelet Pselectin: The molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 2001;86:214-221
25. Dennis MS, Henzel WJ, Pitti RM, Lipari MT, Napier MA, Deisher TA, Bunting S, Lazarus RA. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: Evidence for a family of platelet-aggregation inhibitors. Proc Natl Acad Sci USA 1990;87:2471-2475
26. Scarborough RM, Rose JW, Hsu MA, Phillips DR, Fried VA, Campbell AM, Nannizzi L, Charo IF, Barbourin A. GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J Biol Chem 1991;266:9359-9362
27. Mazurov AV, Pevzner DV, Antonova OA, Byzova TV, Khaspekova SG, Semenov AV, Vlasik TN, Samko AN, Staroverov II, Ruda MY. Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty. Platelets 2002;13:465-477
28. Berndt MC, Du XP, Booth WJ. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1988;27:633-640
29. Dunlop LC, Skinner MP, Bendall LJ, Favaloro EJ, Castaldi PA, Gorman JJ, Gamble JR, Vadas MA, Berndt MC. Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med 1992;175:1147-1150
30. Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962;194:927-929
31. Gabbasov ZA, Popov EG, Gavrilov I, Pozin E. Platelet aggregation: The use of optical density fluctuations to study microaggregate formation in platelet suspension. Thromb Res 1989;54: 215-223
32. Packham MA, Guccione MA, Nina M, Kinlough-Rathbone RL, Mustard JF. Effects of tris on responses of human and rabbit platelets to aggregating agents. Thromb Haemost 1984;51: 140-144
33. Eggerman TL, Mondoro TH, Lozier JN, Vostal JG. Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation. Hum Gene Ther 2002;13:125-128
34. Kalvegren H, Majeed M, Bengtsson T. Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: A causal role in cardiovascular disease? Arterioscler Thromb Vasc Biol 2003;23:1677-1683
35. Danon D, Jerushalmy Z, De Vries A. Incorporation of influenza virus in human blood platelets in vitro. Electron microscopical observation. Virology 1959;9:719-722
36. Zucker-Franklin D, Seremetis S, Zheng ZY. Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets. Blood 1990;75: 1920-1923
37. Rand ML, Wright JF. Virus-associated idiopathic thrombocytopenic purpura. Transfus Sci 1998;19:253-259
38. de Almeida AJ, Campos-de-Magalhaes M, Brandao-Mello CE, de Oliveira RV, Yoshida CF, Lampe E. Detection of hepatitis C virus in platelets: Evaluating its relationship to viral and host factors. Hepatogastroenterology 2007;54:964-968
39. Boukour S, Masse JM, Benit L, Dubart-Kupperschmitt A, Cramer EM. Lentivirus degradation and DC-SIGN expression by human platelets and megakaryocytes. J Thromb Haemost 2006;4:426-435
40. Boukour S, Cramer EM. Platelet interaction with bacteria. Platelets 2005;16:215-217
41. Hofherr SE, Mok H, Gushiken FC, Lopez JA, Barry MA. Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia. Hum Gene Ther 2007;18:837-848